← Browse by Condition
Medical Condition
overweight
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for overweight sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — overweight Clinical Trials
How many clinical trials are currently recruiting for overweight?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for overweight, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for overweight?
overweight research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a overweight clinical trial?
Eligibility criteria for overweight trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 2
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Enrollment
1,217 pts
Location
United States, Argen...
Sponsor
Eli Lilly and Company
NCT07199283
Recruiting
The PreEclampsia Postpartum Prevention Trial
Enrollment
356 pts
Location
Sweden
Sponsor
Karolinska Institutet
NCT06557317
Recruiting
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
Enrollment
60 pts
Location
United States
Sponsor
Cornell University
NCT07472881
Recruiting
Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women
Enrollment
40 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07090005
Recruiting
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Enrollment
184 pts
Location
United States
Sponsor
Nitinotes Surgical Ltd.
NCT07392190 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Enrollment
900 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
NCT07411560 Phase 1
Recruiting
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
Enrollment
100 pts
Location
United Kingdom
Sponsor
Novo Nordisk A/S
NCT07009171 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
Enrollment
75 pts
Location
South Korea
Sponsor
NeuroBiogen Co., Ltd
NCT06982131 Phase 1
Recruiting
A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
Enrollment
40 pts
Location
Netherlands
Sponsor
Hoffmann-La Roche
NCT07036692
Recruiting
The FaibaGo Study - Long-Term Weight Reduction Via Low-Threshold Intervention
Enrollment
120 pts
Location
Switzerland
Sponsor
University of Bern
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology